RACHEL EASTERWOOD: Open Payments
NPI 1053913160 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 45 payments from 9 companies in 2025. Trend: 2023 $153 · 2024 $494 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $264 |
| Sumitomo Pharma America, Inc. | 9 | $164 |
| Lilly USA, LLC | 3 | $158 |
| Astellas Pharma US Inc | 5 | $109 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $107 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $29 |
| Organon LLC | 1 | $27 |
Products named: Wegovy, MYFEMBREE, ZEPBOUND, Veozah, Auvelity, TRINTELLIX, ORILISSA, NEXPLANON.
Industry payments across GA — which companies pay providers there.
